Pathology and Classification of Thyroid Tumors

Chapter
Part of the Endocrine Updates book series (ENDO, volume 32)

Abstract

Nodules of the thyroid gland are common and frequently problematic specimens encountered by the diagnostic surgical pathologist. It is estimated that 4–7% of adults have a palpable thyroid nodule, and several times that many have nodules which are detectable at autopsy or by ultrasound. Of the estimated 10–20 million clinically detectable thyroid lesions in the United States, approximately 5–30% will be malignant. Thyroid nodules are more common in women, in people with a history of radiation exposure, and in those with goitrogenic-rich diets or iodine-deficient diets (Faquin, Arch Pathol Lab Med 132:622–632, 2008). Carcinomas of follicular cell origin are the most common and greatly outnumber carcinomas of C-cell origin. Secondary malignancies and lymphomas are far less common than follicular origin tumors, but they do occur and must be considered in the differential diagnosis of both benign and malignant thyroid abnormalities. The majority of carcinomas of follicular origin are indolent, with approximately 90% 10-year survival rates.

Keywords

Thyroid gland Thyroid nodules Follicular neoplasm Thyroid carcinoma Hurthle cell carcinoma Histologic variants of papillary carcinoma 

References

  1. 1.
    Faquin WC. Recurring problems in histologic and cytologic evaluation. Arch Pathol Lab Med. 2008;132:622–32.PubMedGoogle Scholar
  2. 2.
    Peng Y, Wang HH. A meta-analysis of comparing fine-needle aspiration and frozen section for evaluating thyroid nodules. Diagn Cytopathol. 2008;36:916–20.PubMedGoogle Scholar
  3. 3.
    Kingston GW, Bugis SP, Davis N. Role of frozen section and clinical parameters in distinguishing benign from malignant follicular neoplasms of the thyroid. Am J Surg. 1992;164:603–5.PubMedGoogle Scholar
  4. 4.
    DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics: tumors of endocrine organs. Lyon: IARC Press; 2004.Google Scholar
  5. 5.
    Livolsi VA, Baloch ZW. Use and abuse of frozen section in the diagnosis of follicular thyroid lesions. Endocr Pathol. 2005;16:285–93.PubMedGoogle Scholar
  6. 6.
    Leteurtre E, Leroy X, Pattou F, Wacrenier A, Carnaille B, Proye C, et al. Why do frozen sections have limited value in encapsulated or minimally invasive follicular carcinoma of the thyroid? Am J Clin Pathol. 2001;115:370–4.PubMedGoogle Scholar
  7. 7.
    Rosen Y, Rosenblatt P, Saltzman E. Intraoperative pathologic diagnosis of thyroid neoplasms: report on experience with 504 specimens. Cancer. 1990;66:2001–6.PubMedGoogle Scholar
  8. 8.
    Brooks AD, Shaha AR, DuMornay W, Huvos AG, Zakowski M, Brennan MF, et al. Role of fine needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors. Ann Surg Oncol. 2001;8:92–100.PubMedGoogle Scholar
  9. 9.
    McHenry CR, Raeburn C, Strickland T, Marty JJ. The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg. 1996;172:658–61.PubMedGoogle Scholar
  10. 10.
    Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL. Randomized prospective evaluation of frozen section analysis for follicular neoplasms of the thyroid. Ann Surg Oncol. 2001;233:716–22.Google Scholar
  11. 11.
    Callcut RA, Selvaggi SM, Mack E, Ozgul O, Warner T, Chen H. The utility of frozen section evaluation for follicular thyroid lesions. Ann Surg Oncol. 2003;11:94–8.Google Scholar
  12. 12.
    Roach JC, Heller KS, Dubner S, Sznyter LA. The value of frozen section examinations in determining the extent of thyroid surgery in patients with indeterminate fine needle aspiration cytology. Arch Otolaryngol Head Neck Surg. 2002;128:263–7.PubMedGoogle Scholar
  13. 13.
    Zambudio AR, Gonzales JMR, Perez JS, Cogollos TS, Fernandez PJG, Paricio PP. Utility of frozen ­section examination for diagnosis of malignancy associated with multinodular goiter. Thyroid. 2004;14:600–4.Google Scholar
  14. 14.
    Franc B, De La Salmoniere P, Lange F, Hoang C, Louvel A, De Roquancourt A, et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol. 2003;34:1092–100.PubMedGoogle Scholar
  15. 15.
    Baloch ZW, LiVolsi VA. Our approach to follicular patterned lesions of the thyroid. J Clin Pathol. 2007;60:244–50.PubMedGoogle Scholar
  16. 16.
    Baloch ZW, LiVolsi VA. Follicular patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117:143–50.PubMedGoogle Scholar
  17. 17.
    Livolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: views, biases, and experiences. Adv Anat Pathol. 2004;11:279–87.PubMedGoogle Scholar
  18. 18.
    Serra S, Asa SL. Controversies in thyroid pathology: the diagnosis of follicular neoplasms. Endocr Pathol. 2008;19:156–65.PubMedGoogle Scholar
  19. 19.
    Baloch ZW, Livolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Am J Clin Pathol. 2006;125 Suppl 1:S135–44.PubMedGoogle Scholar
  20. 20.
    Pandit AA, Phulpagar MD. Worrisome histologic alterations following fine needle aspiration of the thyroid. Acta Cytol. 2001;45:173–9.PubMedGoogle Scholar
  21. 21.
    Thompson LDR, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91:505–24.PubMedGoogle Scholar
  22. 22.
    DeLillis RA. Pathology and genetics of thyroid carcinoma. J Surg Oncol. 2006;94:662–9.Google Scholar
  23. 23.
    Medeiros-Neto G, Gil-Da-Costa MJ, Santos CLS, Medina M, Silva JCE, Tsou RM, et al. Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroid peroxidase gene. J Clin Endocrinol Metab. 1998;83:4162–6.PubMedGoogle Scholar
  24. 24.
    Alzahrani AS, Baitei EY, Zou M, Shi Y. Metastatic follicular thyroid carcinoma arising from congenital goiter as a result of a novel splice donor site mutation in the thyroglobulin gene. J Clin Endocrinol Metab. 2006;91:740–6.PubMedGoogle Scholar
  25. 25.
    Lin JD, Chao TC, Hsueh C. Follicular carcinomas with lung metastases: a 23 year retrospective study. Endocr J. 2004;51:519–225.Google Scholar
  26. 26.
    Ashfaq R, Vuitch F, Delgado R, Albores-Saavedra J. Papillary and follicular thyroid carcinomas with insular component. Cancer. 1994;73:416–23.PubMedGoogle Scholar
  27. 27.
    Ghossein R. Problems and controversies in the histopathology of thyroid carcinomas of follicular cell ­origin. Arch Pathol Lab Med. 2009;133:683–91.PubMedGoogle Scholar
  28. 28.
    Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002;26:1508–14.PubMedGoogle Scholar
  29. 29.
    Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (Encapsulated) follicular and Hurthle cell carcinoma: a study of 34 patients. Mod Pathol. 2000;13:123–30.PubMedGoogle Scholar
  30. 30.
    Hofman V, Lasalle S, Bonnetaud C, Butori C, Laoubatier C, Ilie M, et al. Thyroid tumors of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch. 2009;455:21–33.PubMedGoogle Scholar
  31. 31.
    Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (Oncocytic) Cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 2008;132:1241–50.PubMedGoogle Scholar
  32. 32.
    Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol. 2002;160:1857–65.PubMedGoogle Scholar
  33. 33.
    Asa SL. My approach to oncocytic tumors of the thyroid. J Clin Pathol. 2004;57:225–32.PubMedGoogle Scholar
  34. 34.
    Ghossen RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, et al. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland. Cancer. 2006;106:1669–76.Google Scholar
  35. 35.
    Har-el G, Hadar T, Segal K, Levy R, Sidi J. Hurthle cell carcinoma of the thyroid gland: a tumor of moderate malignancy. Cancer. 1986;57:1613–7.PubMedGoogle Scholar
  36. 36.
    Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer. 2003;97:1186–94.PubMedGoogle Scholar
  37. 37.
    Arganini M, Behar R, Wu TC, Straus F, McCormick M, DeGroot LJ, et al. Hurthle cell tumors: a twenty-five year experience. Surgery. 1986;100:1108–15.PubMedGoogle Scholar
  38. 38.
    Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery. 1995;118:1131–8.PubMedGoogle Scholar
  39. 39.
    Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Haas OA, Vierhapper H, et al. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol. 2001;25:1245–51.PubMedGoogle Scholar
  40. 40.
    Etite D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: at study of 42 cases. Arch Pathol Lab Med. 2008;132:1767–73.Google Scholar
  41. 41.
    Livolsi VA, Feind CR. Incidental medullary thyroid carcinoma in sporadic hyperparathyroidism. An expansion of the concept of C-cell hyperplasia. Am J Clin Pathol. 1979;71:595–9.PubMedGoogle Scholar
  42. 42.
    Bergholm U, Bergstrom R, Ekbom A. Long term follow up of patients with medullary carcinoma of the thyroid. Cancer. 1997;79:132–8.PubMedGoogle Scholar
  43. 43.
    Scopsi L, Sampietro G, Boracchi P, Del Bo R, Gullo M, Placucci M, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: a retrospective review of 109 consecutive patients. Cancer. 1996;78:2173–83.PubMedGoogle Scholar
  44. 44.
    Franc B, Rosenberg-Bourgin M, Caillou B, Dutrieux-Berger N, Floquet J, Houcke-LeComte M, et al. Medullary thyroid carcinoma: Search for histological predictors of survival (109 Proband cases analysis). Hum Pathol. 1998;29:1078–84.PubMedGoogle Scholar
  45. 45.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Fl G, Trotto A, editors. AJCC Cancer staging manual. 7th ed. New York, NY: Springer; 2010.Google Scholar
  46. 46.
    Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 1987;11:583–91.PubMedGoogle Scholar
  47. 47.
    Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. Am J Surg Pathol. 2004;28:859–67.PubMedGoogle Scholar
  48. 48.
    McCluggage WG, Sloan JM. Hyalinizing trabecular carcinoma of thyroid gland. Histopathology. 1996;28:357–62.PubMedGoogle Scholar
  49. 49.
    Gonzalez-Campora R, Fuentes-Vaamonde E, Hevia-Vazquez A, Otal-Salaverri C, Villar-Rodriguez JL, Galera-Davidson H. Hyalinizing trabecular carcinoma of the thyroid gland: report of two cases of follicular cell thyroid carcinoma with hyalinizing trabecular pattern. Ultrastruct Pathol. 1998;22:39–46.PubMedGoogle Scholar
  50. 50.
    Molberg K, Albores-Saavedra J. Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol. 1994;25:192–7.PubMedGoogle Scholar
  51. 51.
    Papotti M, Volante M, Giuliano A, Fassina A, Fusco A, Bussolati G, et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol. 2000;24:1615–21.PubMedGoogle Scholar
  52. 52.
    Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7.PubMedGoogle Scholar
  53. 53.
    Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population based study of 15, 698 cases from the surveillance, epidemiology, and end results (SEER) program 1973–1991. Cancer. 1997;79:564–73.PubMedGoogle Scholar
  54. 54.
    Baloch ZW, LiVolsi VA. Etiology and significance of the “optically clear nucleaus”. Endocr Pathol. 2002;13:289–99.PubMedGoogle Scholar
  55. 55.
    Llyod RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.Google Scholar
  56. 56.
    Elsheikh TM, Asa SL, Chan JKC, DeLellis RA, Heffess CS, LiVolsi VA, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008;130:736–44.PubMedGoogle Scholar
  57. 57.
    Chan JKC. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002;117:16–8.PubMedGoogle Scholar
  58. 58.
    Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol. 2000;13:861–5.PubMedGoogle Scholar
  59. 59.
    Ghossein R, LiVolsi VA. Papillary thyroid carcinoma tall cell variant. Thyroid. 2008;18:1179–81.PubMedGoogle Scholar
  60. 60.
    Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988;12:22–7.PubMedGoogle Scholar
  61. 61.
    Gaertner EM, Davidson M, Wenig BM. The columnar cell variant of thyroid papillary carcinoma: case report and discussion of an unusually aggressive thyroid papillary carcinoma. Am J Surg Pathol. 1995;19:940–7.PubMedGoogle Scholar
  62. 62.
    Wenig BM, Thompson LDR, Adair CF, Shmookler B, Heffess CS. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer. 1998;82:740–53.PubMedGoogle Scholar
  63. 63.
    Lugli A, Terracciano LM, Oberholzer M, Bubendorf L, Tornillo L. Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and Immunohistochemical study of 3 cases and review of the literature. Arch Pathol Lab Med. 2004;128:54–8.PubMedGoogle Scholar
  64. 64.
    Albores-Saavedra J, Gould E, Vardaman C, Vuitch F. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol. 1991;22:1195–205.PubMedGoogle Scholar
  65. 65.
    Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol. 1997;28:47–53.PubMedGoogle Scholar
  66. 66.
    Baloch ZW, LiVolsi VA. Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med. 2000;124:1192–5.PubMedGoogle Scholar
  67. 67.
    Thompson LDR, Wieneke JA, Heffess CS. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases. Endocr Pathol. 2005;16:331–48.PubMedGoogle Scholar
  68. 68.
    Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma: clinicopathologic study of 15 cases. Am J Surg Pathol. 1989;13:1040–9.Google Scholar
  69. 69.
    Fujimoto Y, Obara T, Ito Y, Kodama T, Aiba M, Yamaguchi K. Diffuse sclerosing variant of papillary carcinoma of the thyroid: clinical importance, surgical treatment, and follow up study. Cancer. 1990;66:2306–12.PubMedGoogle Scholar
  70. 70.
    Hirokawa M, Kuma S, Miyauchi A, Qian ZR, Nakasono M, Sano T, et al. Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia. APMIS. 2004;112:275–82.PubMedGoogle Scholar
  71. 71.
    Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol. 2006;13:69–75.PubMedGoogle Scholar
  72. 72.
    Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31:1256–64.PubMedGoogle Scholar
  73. 73.
    Sanders EM, LiVolsi VA, Brierley J, Shin J, Randolph GW. An evidence based review of poorly differentiated thyroid cancer. World J Surg. 2007;31:934–45.PubMedGoogle Scholar
  74. 74.
    Rufini V, Salvatori M, Fadda G, Pinnarelli L, Castaldi P, Maussier ML, et al. Thyroid carcinomas with variable insular component: prognostic significance of histopathologic patterns. Cancer. 2007;110:1209–17.PubMedGoogle Scholar
  75. 75.
    Pellegriti G, Giuffrida D, Scollo C, Vigneri R, Regalbuto C, Squatrito S, et al. Long term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer. 2002;95:2076–85.PubMedGoogle Scholar
  76. 76.
    Venkatesh YSS, Ordonez NG, Shultz PN, Huckey RC, Goepfert H, Sammaan NA. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer. 1990;66:321–30.PubMedGoogle Scholar
  77. 77.
    Hurlimann J, Gardiol D, Scazziga B. Immunohistology of anaplastic thyroid carcinoma. A study of 43 cases. Histopathology. 1987;11:567–80.PubMedGoogle Scholar
  78. 78.
    Papi G, Corrado S, LiVolsi VA. Primary spindle cell lesions of the thyroid gland. Am J Clin Pathol. 2005;124 Suppl 1:S95–S123.Google Scholar
  79. 79.
    Derringer GA, Thompson LDR, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623–39.PubMedGoogle Scholar
  80. 80.
    Skacel M, Ross CW, His ED. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B cell lymphoma. Histopathology. 2000;37:10–8.PubMedGoogle Scholar
  81. 81.
    Wenig BM, Adair CF, Heffess CS. Primary mucoepidermoid carcinoma of the thyroid gland: a report of six cases and a review of the literature of a follicular epithelial derived tumor. Hum Pathol. 1995;26:1099–108.PubMedGoogle Scholar
  82. 82.
    Baloch ZW, Solomon AC, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol. 2000;13:802–7.PubMedGoogle Scholar
  83. 83.
    Ando M, Nakanishi Y, Asai M, Maeshima A, Matsuno Y. Mucoepidermoid carcinoma of the thyroid gland showing marked ciliation suggestive of its pathogenesis. Pathol Int. 2008;58:741–4.PubMedGoogle Scholar
  84. 84.
    Baloch ZW, LiVolsi VA. Unusual tumors of the thyroid gland. Endocrinol Metab Clin North Am. 2008;37:297–310.PubMedGoogle Scholar
  85. 85.
    Sim SJ, Ro JY, Ordonez NG, Cleary KR, Ayala AG. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: report of two patients, one with distant metastasis, and review of the literature. Hum Pathol. 1997;28:1091–6.PubMedGoogle Scholar
  86. 86.
    Cheuk W, Jacobson AA, Chan JKC. Spindle epithelial tumor with thymus-like differentiation (SETTLE): a distinctive malignant thyroid neoplasm with significant metastatic potential. Mod Pathol. 2000;13:1150–5.PubMedGoogle Scholar
  87. 87.
    Folpe AL, Lloyd RV, Bacchi CE, Rosai J. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Am J Surg Pathol. 2009;33:1179–86.PubMedGoogle Scholar
  88. 88.
    Reimann JDR, Dorfman DM, Nose V. Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study. Evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol. 2006;30:994–1001.PubMedGoogle Scholar
  89. 89.
    Ito Y, Miyauchi A, Nakamura Y, Miya A, Kobayashi K, Kakudo K. Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation. A collaborative study with member institutes of the Japanese Society of Thyroid Surgery. Am J Clin Pathol. 2007;127:230–6.PubMedGoogle Scholar
  90. 90.
    Thompson LDR, Rosai J, Heffess CS. Primary thyroid teratomas: a clinicopathologic study of 30 cases. Cancer. 2000;88:1149–58.PubMedGoogle Scholar
  91. 91.
    Martins T, Carrillo M, Gomes L, Mesquita C, Martins M, Carvalheiro M. Malignant teratoma of the thyroid: case report. Thyroid. 2006;16:1311–3.PubMedGoogle Scholar
  92. 92.
    Nishihara E, Miyauchi A, Hirokawa M, Kudo T, Ohye H, Ito M, et al. Benign thyroid teratomas manifest painful cystic and solid composite nodules. Endocr J. 2006;30:231–6.Google Scholar
  93. 93.
    Papotti M, Arrondini M, Tavaglione V, Veltri A, Volante M. Diagnostic controversies in vascular proliferation of the thyroid gland. Endocr Pathol. 2008;19:175–83.PubMedGoogle Scholar
  94. 94.
    Ryska A, Ludvikova M, Szepe P, Boor A. Epithelioid haemangiosarcoma of the thyroid gland. Report of six cases from a non-Alpine region. Histopathology. 2004;44:40–6.PubMedGoogle Scholar
  95. 95.
    Maiorana A, Collina G, Cesinaro AM, Fano RA, Eusebi V. Epithelioid angiosarcoma of the thyroid. Clinicopathological analysis of seven cases from non-Alpine areas. Virchows Arch. 1996;429:131–7.PubMedGoogle Scholar
  96. 96.
    Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, et al. BRAF mutations and RET/PTC rearrangements are alternative events in etiopathogenesis of PTC. Oncogene. 2003;22:4578–80.PubMedGoogle Scholar
  97. 97.
    Nikiforov YE. RET/PTC Rearrangement in thyroid tumors. Endocr Pathol. 2002;13:13.Google Scholar
  98. 98.
    Xiulong X, Quiros RM, Gattuso P, Ain KB, Prinz RA. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res. 2003;63:4561–7.Google Scholar
  99. 99.
    Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005;90:6373–9.PubMedGoogle Scholar
  100. 100.
    Volante M, Rapa I, Gandhi M, Bussolati G, Giachino D, Papotti M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab. 2009;94:4735–41.PubMedGoogle Scholar
  101. 101.
    Eberhardt NL, Grebe SKG, McIver B, Reddi HV. The role of PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer. Mol Cell Endocrinol. 2010;321:50–6.PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Pathology and Lab MedicineCedars-Sinai Medical CenterLos AngelesUSA
  2. 2.Department of Pathology and Lab MedicineCedars-Sinai Medical CenterLos AngelesUSA

Personalised recommendations